Diabetic nephropathy affects approximately a third of patients with type 1 and type 2 diabetes mellitus. Diabetic nephropathy is responsible for about a third of<unk> s of ESRD worldwide, and an even larger fraction in the developed countries. Worldwide, the prevalence of diabetes is projected to increase from 382 million in 2013, to over 592 million by 2035. This increase is projected to be sharpest in developed countries. The prevalence of type 2 DM is particularly increasing due to the rising prevalence of obesity worldwide. Diabetic kidney disease progression could lead to ESRD as well as an increased risk of cardiovascular complications, all of which<unk>  a substantial economic burden. The estimated cost of management of patients with ESRD due to diabetic nephropathy in the US is 39.35 billion USD in 2010. Within developed countries, certain ethnic groups such as African Americans and Native Americans are at higher risk of developing diabetic nephropathy and ESRD.
medical cause of Chronic kidney disease
symptom of Kidney cancer
complications of Kidney disease
symptom of Renal papillary necrosis
medical cause of Pyelonephritis
medical cause of Polyuria
complications of Acute liver failure
medical cause of Hematuria